Table 4 Genotype and allele frequency among RA patients and controls
From: Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Genotype | Patients (n = 120) | Controls (n = 90) | P value | Relative risk | O.R. |
|---|---|---|---|---|---|
70% (84/120) | 68.90% (62/90) | 0.862* | 1.02 | 1.05 | |
RR | 17.5% (21/120) | 20% (18/90) | 0.644* | 0.93 | 0.85 |
QR | 12.5 (15/120) | 11.10% (10/90) | 0.758* | 1.06 | 1.14 |
| Â | Allele frequency | Â | Â | Â | |
Q | 183 (76.26%) | 134 (74.44%) | 0.670* | 1.04 | 1.10 |
R | 57 (23.74%) | 46 (25.56%) | |||